{"id":498764,"date":"2021-05-26T08:04:12","date_gmt":"2021-05-26T12:04:12","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-investor-conferences-in-june-2021\/"},"modified":"2021-05-26T08:04:12","modified_gmt":"2021-05-26T12:04:12","slug":"cortexyme-to-present-at-investor-conferences-in-june-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-investor-conferences-in-june-2021\/","title":{"rendered":"Cortexyme to Present at Investor Conferences in June 2021"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Cortexyme to Present at Investor Conferences in June 2021<\/b><\/p>\n<p>SOUTH SAN FRANCISCO, Calif.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nCortexyme, Inc. (Nasdaq: CRTX), a company advancing a pivotal trial in Alzheimer&#8217;s disease with topline data expected in the fourth quarter of 2021 and a growing pipeline of therapeutics for degenerative diseases, announced that Chris Lowe, the company\u2019s chief operating officer and chief financial officer, will participate at the following virtual investor conferences in June 2021:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nJefferies Healthcare Conference on Wednesday, June 2, 2021, at 2:00 p.m. EDT (11:00 a.m. PDT).\n<\/li>\n<li>\nThe JMP Securities Life Sciences Conference on Wednesday, June 16, 2021 at 3:00 p.m. EDT (12:00 p.m. PDT).\n<\/li>\n<\/ul>\n<p>\nA live webcast of the events will be accessible on the <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fir.cortexyme.com%2Fnews-and-events%2Finvestor-calendar&amp;esheet=52435544&amp;newsitemid=20210526005260&amp;lan=en-US&amp;anchor=Investor+Calendar&amp;index=1&amp;md5=c31cfc90cc3984ace96049c19fa31b7f\">Investor Calendar<\/a> page under the News &amp; Events heading of Cortexyme\u2019s investor website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fir.cortexyme.com%2F&amp;esheet=52435544&amp;newsitemid=20210526005260&amp;lan=en-US&amp;anchor=ir.cortexyme.com&amp;index=2&amp;md5=1d2d592358711ce476eb11337a8c5a69\">ir.cortexyme.com<\/a>. The webcasts will be archived at that location for 90 days.\n<\/p>\n<p><b>About Cortexyme<\/b><\/p>\n<p>\nCortexyme, Inc. (Nasdaq: CRTX) is a clinical stage biopharmaceutical company pioneering upstream therapeutic approaches designed to improve the lives of patients diagnosed with Alzheimer\u2019s and other degenerative diseases. The company is advancing its disease-modifying pivotal GAIN Trial in mild to moderate Alzheimer&#8217;s disease with top-line data expected in the fourth quarter of 2021, in addition to growing a proprietary pipeline of first-in-class small molecule therapeutics for Parkinson\u2019s disease, periodontitis, and other diseases with high unmet clinical need. Cortexyme\u2019s lead program targets a specific, infectious pathogen called P. gingivalis found in the brain and other organs and tied to degeneration and inflammation in humans and animal models. The company\u2019s causation evidence for Alzheimer\u2019s disease and the mechanism of its novel therapeutic has been independently replicated and confirmed by multiple laboratories around the world, as well as published in peer-reviewed scientific journals. To learn more about Cortexyme, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.cortexyme.com&amp;esheet=52435544&amp;newsitemid=20210526005260&amp;lan=en-US&amp;anchor=www.cortexyme.com&amp;index=3&amp;md5=1186b676722c8a6eb7bcc537d8d559b7\">www.cortexyme.com<\/a> or follow @Cortexyme on Twitter.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210526005260r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210526005260\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210526005260\/en\/<\/a><\/span><\/p>\n<p><b>Corporate Contact:<br \/>\n<\/b><br \/>Stacy Roughan<br \/>\n<br \/>Vice President, Corporate Communications &amp; Investor Relations<br \/>\n<br \/>Cortexyme, Inc.<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:IR@cortexyme.com\">IR@cortexyme.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> California United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Health Consumer Seniors Dental Clinical Trials Pharmaceutical Biotechnology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210526005260\/en\/1091862\/3\/logo_large_jpg.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Cortexyme to Present at Investor Conferences in June 2021 SOUTH SAN FRANCISCO, Calif.&#8211;(BUSINESS WIRE)&#8211; Cortexyme, Inc. (Nasdaq: CRTX), a company advancing a pivotal trial in Alzheimer&#8217;s disease with topline data expected in the fourth quarter of 2021 and a growing pipeline of therapeutics for degenerative diseases, announced that Chris Lowe, the company\u2019s chief operating officer and chief financial officer, will participate at the following virtual investor conferences in June 2021: Jefferies Healthcare Conference on Wednesday, June 2, 2021, at 2:00 p.m. EDT (11:00 a.m. PDT). The JMP Securities Life Sciences Conference on Wednesday, June 16, 2021 at 3:00 p.m. EDT (12:00 p.m. PDT). A live webcast of the events will be accessible on the Investor Calendar page under the News &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-investor-conferences-in-june-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Cortexyme to Present at Investor Conferences in June 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-498764","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cortexyme to Present at Investor Conferences in June 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-investor-conferences-in-june-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cortexyme to Present at Investor Conferences in June 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Cortexyme to Present at Investor Conferences in June 2021 SOUTH SAN FRANCISCO, Calif.&#8211;(BUSINESS WIRE)&#8211; Cortexyme, Inc. (Nasdaq: CRTX), a company advancing a pivotal trial in Alzheimer&#8217;s disease with topline data expected in the fourth quarter of 2021 and a growing pipeline of therapeutics for degenerative diseases, announced that Chris Lowe, the company\u2019s chief operating officer and chief financial officer, will participate at the following virtual investor conferences in June 2021: Jefferies Healthcare Conference on Wednesday, June 2, 2021, at 2:00 p.m. EDT (11:00 a.m. PDT). The JMP Securities Life Sciences Conference on Wednesday, June 16, 2021 at 3:00 p.m. EDT (12:00 p.m. PDT). A live webcast of the events will be accessible on the Investor Calendar page under the News &hellip; Continue reading &quot;Cortexyme to Present at Investor Conferences in June 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-investor-conferences-in-june-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-26T12:04:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210526005260r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-investor-conferences-in-june-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-investor-conferences-in-june-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cortexyme to Present at Investor Conferences in June 2021\",\"datePublished\":\"2021-05-26T12:04:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-investor-conferences-in-june-2021\\\/\"},\"wordCount\":356,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-investor-conferences-in-june-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210526005260r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-investor-conferences-in-june-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-investor-conferences-in-june-2021\\\/\",\"name\":\"Cortexyme to Present at Investor Conferences in June 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-investor-conferences-in-june-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-investor-conferences-in-june-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210526005260r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-05-26T12:04:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-investor-conferences-in-june-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-investor-conferences-in-june-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-investor-conferences-in-june-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210526005260r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210526005260r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-investor-conferences-in-june-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cortexyme to Present at Investor Conferences in June 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cortexyme to Present at Investor Conferences in June 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-investor-conferences-in-june-2021\/","og_locale":"en_US","og_type":"article","og_title":"Cortexyme to Present at Investor Conferences in June 2021 - Market Newsdesk","og_description":"Cortexyme to Present at Investor Conferences in June 2021 SOUTH SAN FRANCISCO, Calif.&#8211;(BUSINESS WIRE)&#8211; Cortexyme, Inc. (Nasdaq: CRTX), a company advancing a pivotal trial in Alzheimer&#8217;s disease with topline data expected in the fourth quarter of 2021 and a growing pipeline of therapeutics for degenerative diseases, announced that Chris Lowe, the company\u2019s chief operating officer and chief financial officer, will participate at the following virtual investor conferences in June 2021: Jefferies Healthcare Conference on Wednesday, June 2, 2021, at 2:00 p.m. EDT (11:00 a.m. PDT). The JMP Securities Life Sciences Conference on Wednesday, June 16, 2021 at 3:00 p.m. EDT (12:00 p.m. PDT). A live webcast of the events will be accessible on the Investor Calendar page under the News &hellip; Continue reading \"Cortexyme to Present at Investor Conferences in June 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-investor-conferences-in-june-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-05-26T12:04:12+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210526005260r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-investor-conferences-in-june-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-investor-conferences-in-june-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cortexyme to Present at Investor Conferences in June 2021","datePublished":"2021-05-26T12:04:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-investor-conferences-in-june-2021\/"},"wordCount":356,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-investor-conferences-in-june-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210526005260r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-investor-conferences-in-june-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-investor-conferences-in-june-2021\/","name":"Cortexyme to Present at Investor Conferences in June 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-investor-conferences-in-june-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-investor-conferences-in-june-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210526005260r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-05-26T12:04:12+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-investor-conferences-in-june-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-investor-conferences-in-june-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-investor-conferences-in-june-2021\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210526005260r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210526005260r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-investor-conferences-in-june-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cortexyme to Present at Investor Conferences in June 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/498764","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=498764"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/498764\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=498764"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=498764"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=498764"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}